[Blocking p38 signal pathway lowers MMP-9 expression and reduces brain edema in rats with traumatic brain injury]

Zhaohua Tang1, Zhengbu Liao, Quanhong Shi

  • 1Department of Neurosurgery, First Affiliated Hospital of Chongqing Medical University, China. ducker-1@hotmail.com

Abstract

Insights

Blocking the p38 signal pathway reduces matrix metalloproteinase-9 (MMP-9) upregulation and brain edema following traumatic brain injury (TBI). This highlights p38

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathophysiology

Background:

  • Traumatic brain injury (TBI) is a significant cause of mortality and disability.
  • Brain edema and blood-brain barrier (BBB) disruption are critical complications following TBI.
  • The role of the p38 signal pathway and matrix metalloproteinase-9 (MMP-9) in TBI pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the involvement of the p38 signal pathway in regulating MMP-9 expression and brain edema formation in a rat model of TBI.
  • To determine the therapeutic potential of inhibiting the p38 pathway in TBI.

Main Methods:

  • Adult male Sprague Dawley rats were subjected to TBI using the Feeney free falling method.
  • Groups included normal, sham-operated, TBI, and TBI with SB203580 (p38 inhibitor) treatment.
  • MMP-9 and p38 pathway activation (p-p38) were assessed via RT-PCR and Western blotting.
  • Blood-brain barrier permeability and brain water content were quantified.

Main Results:

  • TBI induced significant p38 pathway activation and increased blood-brain barrier permeability within 2 hours.
  • MMP-9 expression and brain edema formation were significantly elevated at 2 days post-TBI.
  • SB203580 treatment effectively suppressed p38 activation, reduced MMP-9 upregulation, and attenuated BBB disruption and brain edema.

Conclusions:

  • The p38 signal pathway plays a crucial role in mediating MMP-9 upregulation and subsequent brain edema following TBI.
  • Inhibition of the p38 pathway demonstrates a promising therapeutic strategy for mitigating TBI-induced brain edema and secondary injury.